Quadros Bio
QBIView · Standard · The full assessment

The full seven-pillar verdict on one biological.

The complete Quadros Bio methodology, self-serve.

QBIView Standard scores one product or company independently across all seven readiness layers, across 141 questions, and closes with a confidence-interval analysis and an expert narrative that names the risks and the unknowns explicitly. You receive a written report and a debrief call.

QBIView Standard Assessment report, first page (sample): investment readiness score, tier, critical blockers, score by pillar, pillar radar, priority gaps, and relative strengths

Page 1 of a QBIView Standard report (sample). The full report runs thirteen pages.

0

readiness pillars, scored independently

0

questions across the full framework

0

pages in the written expert report

Best for

When Standard fits

  • Investors doing serious diligence on a candidate company
  • Founders preparing for a Series A or strategic round
  • Strategics evaluating a technology for licensing or partnership
  • Companies stress-testing their own evidence package before approaching investors

Deliverables

What you receive

  • Full seven-pillar assessment, each layer scored independently with rationale
  • Confidence interval or uncertainty model where applicable
  • Identified red flags and how they cluster across layers
  • Recommended actions for closing the most important evidence gaps
  • A written expert report and a debrief call with Dr. de Quadros

The seven readiness pillars

01Biological Validity02Product Integrity03Field Translation04Regulatory Pathway05Commercial Viability06Organizational & IP Strength07R&D and Governance

Inside your report

The written expert report you receive.

QBIView Standard is delivered as a written expert report. It opens with a one-page dashboard, then works through every readiness pillar in depth (thirteen pages in the current sample assessment).

01

Investment readiness score

A 0 to 100 score with its confidence range, placed on the four-tier investment structure, from Tier I conviction to Tier IV not yet investable.

02

Claimed vs evidence-verified

Your claimed score alongside the evidence-verified score, so the gap between what is asserted and what is evidenced today is explicit.

03

Critical blockers

Any hard blocker that caps the result regardless of the number, named plainly, with the reason and where to resolve it.

04

Seven-pillar profile

Every pillar scored on a five-point scale with a status, shown as both a table and a radar.

05

Per-pillar deep-dives

A written expert analysis of each pillar: the real strength, the principal gap, and the specific evidence reviewed.

06

Priority gaps and strengths

The bottlenecks to close first, and the levers already in your favour, each scored.

07

How to read the result

What the score means and what it does not: what an informed investor can defensibly conclude today, not a prediction of financial return.

A full sample report is available under NDA on request. The QBIView methodology itself stays proprietary.

The process

How an assessment runs.

01

Scoping

Confirm the company, the assessment scope, the regulatory geography, and the timeline. NDA exchanged if not already in place.

02

Materials

Receive pitch deck, technical dossier, IP materials, trial data, regulatory submissions, and any other relevant documents.

03

Assessment

Apply the seven-pillar framework, with subject-matter specialists from the Expert Network as the technology requires.

04

Report

The written QBIView Standard report is delivered with a debrief call, and an optional follow-up to support gap closure.

Where Standard sits

Three levels, one methodology.

Standard is the right product when the next decision is large enough to justify deeper work, but when expert-led advisory delivery is not yet required. For the same assessment with founder interviews, data-room review, and a debrief call led throughout by Dr. de Quadros, see Standard + Advisory.

Confidential by default. Not sold. Not published. Not shared without permission.

Ready?

Put one biological through the full assessment.

Tell us about the product or company and the decision in front of you. Pricing is confirmed on request, scoped to the assessment. We respond within two business days.